Current Protein Identity:P06210
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-MERIC(240) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 60 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 3 Protein homooligomer Homooligomer;Protein × 20 PDB declaration: eicosameric(20) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 5 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 4 Protein homooligomer Homooligomer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 6 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 5 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1EAH PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 Deposited 1997-07-22 | Assembly 6 Protein homooligomer Homooligomer;Protein × 120 PDB declaration: 120-meric(120) Consistent with protein count |
Chain 1
578–878(301 aa)
Chain 2
69–339(271 aa)
Chain 3
340–577(238 aa)
Chain 4
1–68(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 30 MYR MYRISTIC ACID × 30 | X-RAY DIFFRACTION | mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 | Assembly 1 Protein heterocomplex Heteromer;Protein × 300 PDB declaration: 300-MERIC(300) Consistent with protein count |
Chain 1
602–879(278 aa)
Chain 2
79–340(262 aa)
Chain 3
341–575(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 60 MYR MYRISTIC ACID × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 | Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain 1
602–879(278 aa)
Chain 2
79–340(262 aa)
Chain 3
341–575(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 | Assembly 3 Protein heterocomplex Heteromer;Protein × 25 PDB declaration: 25-meric(25) Consistent with protein count |
Chain 1
602–879(278 aa)
Chain 2
79–340(262 aa)
Chain 3
341–575(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 5 MYR MYRISTIC ACID × 5 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 | Assembly 4 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric(30) Consistent with protein count |
Chain 1
602–879(278 aa)
Chain 2
79–340(262 aa)
Chain 3
341–575(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 6 MYR MYRISTIC ACID × 6 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 3EPF CryoEM structure of poliovirus receptor bound to poliovirus type 2 Deposited 2008-09-29 | Assembly 5 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain 1
602–879(278 aa)
Chain 2
79–340(262 aa)
Chain 3
341–575(235 aa)
Chain 4
2–69(68 aa)
|
Not recorded | SC4 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6-DICHLORO-PHENYL-OXYMETHYL]-BENZENE × 1 MYR MYRISTIC ACID × 1 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.5;10mM Tris-HCl, 20mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 8AYZ Poliovirus type 2 (strain MEF-1) virus-like particle in complex with capsid binder compound 17 Deposited 2022-09-04 | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric(180) Consistent with protein count |
Chain A
579–879(301 aa)
Chain B
1–340(340 aa)
Chain C
342–578(237 aa)
|
Not recorded | SPH SPHINGOSINE × 60 FHK 4-[[4-[1,3-bis(oxidanylidene)isoindol-2-yl]phenyl]sulfonylamino]benzoic acid × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7;1 x DPBS was made from tissue culture grade Dulbecco's Phosphate Buffered Saline (Sigma-Aldrich). 20 mM EDTA was prepared from fresh stocks of buffered EDTA.
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;Single blotting with 3.5ul of sample. Four second blot time and -17 blot force on the vitrobot.
|
Resolution 1.88 Å |
| 9F59 Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a mammalian expression system. Deposited 2024-04-28 | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric(180) Consistent with protein count |
Chain A
579–879(301 aa)
Chain B
2–340(339 aa)
Chain C
341–578(238 aa)
|
Mutation:VP1 V107I, VP1 F134L, VP1 V183L Mutation:VP2 I57V, VP2 D126A Mutation:VP3 Q178L | SPH SPHINGOSINE × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;4 ul of sample blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.30 Å |
| 9F5P Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from an insect cell expression system. Deposited 2024-04-29 | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric(180) Consistent with protein count |
Chain A
579–879(301 aa)
Chain B
2–340(339 aa)
Chain C
341–578(238 aa)
|
Mutation:VP1 V107I, VP1 V134L, VP1 V183L Mutation:VP2 I57V, VP2 D126A Mutation:VP3 Q178L | SPH SPHINGOSINE × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;4 ul of sample blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.60 Å |
| 9H93 Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC6b) from a yeast expression system. Deposited 2024-10-29 | Assembly 1 Protein heterocomplex Heteromer;Protein × 180 PDB declaration: 180-meric(180) Consistent with protein count |
Chain B
1–340(340 aa)
|
Mutation:VP4 I57V, VP2 D57A | SPH SPHINGOSINE × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.40 Å |
| 9H94 Poliovirus type 2 (strain MEF-1) stabilised virus-like particle (PV2 SC5a) from a yeast expression system. Deposited 2024-10-29 | Assembly 1 Protein heterocomplex Heteromer;Protein × 180 PDB declaration: 180-meric(180) Consistent with protein count |
Chain B
1–340(340 aa)
|
Not recorded | SPH SPHINGOSINE × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7;1 x DPBS, 20 mM EDTA, pH 7.0
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE;3ul of sample double blotted for 3.5 seconds with -15 blot force on FEI Vitrobot mark IV.
|
Resolution 2.10 Å |
| 9OCL PV2-10D2 Complex Deposited 2025-04-24 | Assembly 1 Protein heterocomplex Heteromer;Protein × 360 PDB declaration: 360-meric(360) Consistent with protein count |
Chain 1
579–879(301 aa)
Chain 2
70–340(271 aa)
|
Not recorded | PLM PALMITIC ACID × 60 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.65 Å |
| 9OCL PV2-10D2 Complex Deposited 2025-04-24 | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count |
Chain 1
579–879(301 aa)
Chain 2
70–340(271 aa)
|
Not recorded | PLM PALMITIC ACID × 1 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.65 Å |
| 9OCL PV2-10D2 Complex Deposited 2025-04-24 | Assembly 3 Protein heterocomplex Heteromer;Protein × 30 PDB declaration: 30-meric(30) Consistent with protein count |
Chain 1
579–879(301 aa)
Chain 2
70–340(271 aa)
|
Not recorded | PLM PALMITIC ACID × 5 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.65 Å |
| 9OCL PV2-10D2 Complex Deposited 2025-04-24 | Assembly 4 Protein heterocomplex Heteromer;Protein × 36 PDB declaration: 36-meric(36) Consistent with protein count |
Chain 1
579–879(301 aa)
Chain 2
70–340(271 aa)
|
Not recorded | PLM PALMITIC ACID × 6 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.65 Å |
| 9OCL PV2-10D2 Complex Deposited 2025-04-24 | Assembly 5 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count |
Chain 1
579–879(301 aa)
Chain 2
70–340(271 aa)
|
Not recorded | PLM PALMITIC ACID × 1 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.65 Å |